Innovation leads life
Brand
/Pioneering Biopharma Excellence
Trusted Quality, Global Reach
Science for a Healthier Tomorrow
Building a Resilient Life Science Brand
Huayu-PLUS
/Next-Generation R&D Platform
Unlocking Synergistic Potential
Accelerating Therapeutic Innovation
Technology That Transforms Medicine
Partnership
/Global Collaboration Network
Win-Win Growth With Partners
Co-Creating Healthcare Value
Together for a Healthier Future
Core Products
Innovation-driven, quality-first
Beta-Diphosphopyridine Nucleotide (NAD+) Injection Grade
High-purity injection-grade NAD+ (β-Diphosphopyridine Nucleotide) for premium cosmetic ingredients and anti-aging skincare. NAD+, also known as coenzyme I, is a key coenzyme in the body's metabolism, playing a vital role in cellular energy metabolism and DNA repair.
Nicotinamide (Vitamin B3)
Nicotinamide, also known as Vitamin B3 and nicotinic acid amide, is widely used in nutritional supplements and functional foods. It exists in two forms (niacin and nicotinamide) with different pharmacological effects, and has various benefits including skin brightening and barrier enhancement.
β-Nicotinamide Mononucleotide (NMN)
β-Nicotinamide Mononucleotide (NMN) is a derivative of vitamin B3 that serves as a precursor to NAD+. NMN is widely used in nutritional supplements and functional foods to promote anti-aging and health, helping increase NAD+ levels and slow aging.
Nicotinamide Riboside Chloride (NR-CL)
Nicotinamide Riboside Chloride (NR-CL) is a form of vitamin B3 that serves as a highly efficient NAD+ precursor. It is widely used in nutritional supplements and functional foods for anti-aging, energy metabolism, and neuroprotection.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist developed for type 2 diabetes management. It integrates the actions of both incretins into a single molecule, offering once-weekly dosing for effective blood sugar control and weight management.
Semaglutide
Semaglutide is an anti-diabetic medication (GLP-1 receptor agonist) sold under brand names Ozempic, Wegovy, and Rybelsus. It treats type 2 diabetes and chronic weight management with once-weekly injection, offering a long duration of action.
News & Updates
Latest news from Huayu
Huayu Invited to 2025 Biopharma Industry Forum
Our CEO was invited to speak at the industry forum.
Major Breakthrough in Cell Therapy Technology
Our R&D team achieved a key technological breakthrough in cell therapy.
Huayu Biopharma Completes Series B Funding
The company successfully completed Series B funding of 500 million RMB.
Frequently Asked Questions
Common questions and answers about Huayu Biopharma
Cooperation
We welcome various forms of collaboration:
- Technology Licensing: License our patented technologies to partners for commercial development
- Joint R&D: Collaborate with universities, research institutes, and pharma companies on new drug projects
- CDMO Services: Provide full-process services from process development to manufacturing
- Investment Cooperation: Open financing opportunities to jointly advance project development
Please contact our BD team at: partner@huayu-biopharma.com
General
Founded in 2015, Hangzhou Huayu Biopharma Co., Ltd. is a high-tech enterprise focused on innovative biopharmaceutical R&D. Our business covers core areas including cell therapy, recombinant protein drugs, monoclonal antibody drugs, and innovative vaccines.
We have a world-class R&D team composed of returned PhDs and senior industry experts, with a provincial-level enterprise technology center and postdoctoral research station. Guided by the philosophy of "Innovation Ignites Life, Technology Safeguards Health," we are dedicated to translating cutting-edge scientific achievements into patient-benefiting therapies.
We hold the following main certifications and qualifications:
- National High-T Enterprise Certification
- Provincial-Level Enterprise Technology Center
- Postdoctoral Research Workstation
- ISO9001 Quality Management System Certification
- 50+ National Invention Patents Granted
- Multiple products in IND filing stage
Ordering
The ordering process is as follows:
- Submit your request through our Contact Us page
- Our sales team will contact you within 24 hours
- Confirm product specifications, quantity, and delivery timeline
- Sign contract and arrange production/shipping
For urgent orders, please call directly: +86 0571-8888 8888
Products
Our product portfolio mainly includes:
- Cell Therapy Products: CAR-T, TCR-T and other immune cell therapy technologies
- Recombinant Protein Drugs: High-activity cytokines, growth factors, etc.
- Monoclonal Antibodies: Therapeutic mAbs, bispecific antibodies, ADC drugs
- Innovative Vaccines: Cancer vaccines, preventive vaccines
Multiple candidate drugs are currently in preclinical or clinical trial stages.
We have established a comprehensive quality management system:
- GMP-compliant production facilities and QC laboratories
- ISO9001 quality management system certification
- Rigorous quality testing and release procedures for each batch
- Complete traceability system ensuring product quality tracking
- Regular inspections and audits by regulatory authorities